bremelanotide pt141 nasal spray PT-141 (Bremelanotide) Therapy PT-141 Nasal Spray – Biolabs

Purpose The purpose of this report is to provide EMS professionals with situational awareness of COVID-19 illness in pediatric patients

Differential Diagnosis See Vomiting Causes in Children See Vomiting in Pregnancy (Morning Sickness) See Vomiting in Cancer See Psychogenic Vomiting See Medication Induced Vomiting Cannabinoid Hyperemesis Syndrome See Cannabinoid Hyperemesis May be a subset of Cyclic Vomiting Syndrome Chronic Nausea Vomiting Syndrome Other rare conditions with similar presentations Acute Intermittent Porphyria (associated neurologic findings) Disorders of Fatty Acid Metabolism Medium-chain-acyl-CoA Dehydrogenase Deficiency Carnitine palmityltransferase deficiency (deficiency of the mitochondrial translocation) VIII

So I went back to the drawing board and started fresh from scratch

The doses of CoQ10 and L-carnitine used were quite low compared to the typical doses recommended for migraine (300 mg/day) and doses used in inflammation studies (1000 mg to 4000 mg/day)